New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2014
09:10 EDTDDD, KNCAY3D Systems, Konica Minolta enter strategic alliance
3D Systems (DDD) announced that it has entered into a strategic alliance with Konica Minolta Business Solutions U.S.A., (KNCAY) to distribute its complete 3D printing product portfolio through Konica Minolta's nationwide network of dealers and authorized resellers, as well as its direct sales channel. This relationship marks Konica Minolta as the first original equipment manufacturer to sell, support and service 3D printing products through the traditional printer and office equipment channel in the United States. With this alliance, Konica Minolta will enter the rapidly emerging 3D printing market to provide its customers access to additive manufacturing solutions, complementing and expanding its product and services portfolio distributed through its network of dealers in the U.S., as well as its direct distribution. Konica Minolta plans to focus on high-growth industries such as manufacturing/industrial, healthcare and education applications.
News For DDD;KNCAY From The Last 14 Days
Check below for free stories on DDD;KNCAY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
08:02 EDTDDD3D Systems August weekly volatility elevated into Q2 and outlook
Subscribe for More Information
07:33 EDTDDD3D Systems well-positioned to raise 2H14 guidance, says RBC Capital
Subscribe for More Information
July 28, 2014
11:28 EDTDDD3D printer makers fall after Amazon unveils 3D product store
Subscribe for More Information
05:33 EDTKNCAYAkers Biosciences signs feasibility study deal with Konica Minolta
Akers Biosciences (AKER) has signed a feasibility study deal with Konica Minolta, Inc. (KNCAY) to develop a rapid test for the early detection of cardiac muscle tissue damage a condition commonly observed in patients suffering myocardial infarction. Heart attacks are the leading cause of death in U.S., with approximately 1.1M Americans suffering heart attacks each year. Konica Minolta, has asked Akers to study a diagnostic test based on Akers' proprietary Particle Immuno Filtration Assay, or PIFA, technology which, if successful, will facilitate the rapid detection of biomarkers present in a blood sample which can be used to identify cardiac muscle tissue damage. Such tissue damage can occur even at the early stages of a heart attack so early diagnosis could have a significant beneficial impact on patient treatment. The PIFA technology, when combined with Akers' proprietary Rapid Blood Cell Separation Technology, seraSTAT, permits the testing of whole blood from a finger prick sample allowing a test to be carried out in minutes at the point of care. Currently available tests for cardiac muscle tissue damage require a blood draw and the use of an interpretation device; and typically take 20-30 minutes to complete in a laboratory. Konica Minolta, at its own cost, has asked Akers to study a test which can be performed in under 10 minutes, using only a small blood sample obtained from a finger stick; and which can be read visually at the point of care.
July 23, 2014
10:19 EDTDDD3D Systems calls active on renewed takeover speculation
Subscribe for More Information
09:59 EDTDDDRumor: 3D Systems strength attributed to renewed takeover speculation
Subscribe for More Information
July 22, 2014
06:37 EDTDDDPiper recommends buying 3D space following pullback
Piper Jaffray recommends using the recent weakness in shares of 3D printing companies as a buying opportunity, saying its Q2 reseller/industry survey yielded favorable feedback. The firm has Overweight ratings on 3D Systems (DDD), Materialise (MTLS), Materialise (MTLS), Proto Labs (PRLB) and Stratasys (SSYS). It has a Neutral rating on Voxeljet (VJET).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use